Table of Content




1. Report scope & Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary


2. Strategic Recommendations
2.1 APAC region to witness augmented growth in the forecast period.
2.2 Invest in Research and Development activities


3. Global Human Microbiome Market: Product Outlook


4. Global Human Microbiome Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2014-2024


5. Global Human Microbiome Market Segmentation By Product

5.1 Competitive Scenario of Global Human Microbiome Market – By Product
5.2 Probiotics – Market Size and Forecast (2019-2024)
5.3 Prebiotics - Market Size and Forecast (2019-2024)
5.4 Medical Foods - Market Size and Forecast (2019-2024)
5.5 Others - Market Size and Forecast (2019-2024)


6. Global Human Microbiome Market Segmentation By Disease

6.1 Competitive Scenario of Global Human Microbiome – By Disease
6.2 Obesity – Market Size and Forecast (2019-2024)
6.3 Diabetes Type II - Market Size and Forecast (2019-2024)
6.4 Autoimmune Disorder – Market Size and Forecast (2019-2024)
6.5 Cancer – Market Size and Forecast (2019-2024)
6.6 Gastrointestinal Disorder – Market Size and Forecast (2019-2024)
6.7 Others – Market Size and Forecast (2019-2024)


7. Global Human Microbiome Market Segmentation By Application

7.1 Competitive Scenario of Global Human Microbiome: By Application
7.2 Therapeutics – Market Size and Forecast (2019-2024)
7.3 Diagnostics - Market Size and Forecast (2019-2024)


8. Global Human Microbiome Market: Regional Analysis
8.1 Competitive Scenario of Global Human Microbiome: By Region


9. North America Human Microbiome Market: Segmentation By Products, Disease, Application (2019-2024)
9.1 North America Human Microbiome Market: Size and Forecast (2019-2024)
9.2 Market Segmentation By Products (Probiotics, Prebiotics, Medical Food & Other)
9.3 Market Segmentation By Disease (Obesity, Diabetes Type-II, Autoimmune Disorder, Cancer, Gastrointestinal Disorder & Others)
9.4 Market Segmentation By Application (Therapeutics & Diagnostics)

9.5 North America Human Microbiome Market: Country Analysis
9.6 Market Opportunity Chart of North America Human Microbiome Market - By Country, By Value (Year-2024)
9.7 Competitive Scenario of North America Human Microbiome: By Country
9.8 United States Human Microbiome Market: Size and Forecast (2019-2024)
9.9 United States Human Microbiome Market Segmentation By Product, Disease, Application
9.10 Canada Human Microbiome Market: Size and Forecast (2019-2024)
9.11 Canada Human Microbiome Market Segmentation By Product, Disease, Application
9.12 Mexico Human Microbiome Market: Size and Forecast (2019-2024)
9.13 Mexico Human Microbiome Market Segmentation By Products, Disease, Application


10. Europe Human Microbiome Market: Segmentation By Product, Disease, Application (2019-2024)
10.1 Europe Human Microbiome Market: Size and Forecast (2019-2024)
10.2 Market Segmentation By Products (Probiotics, Prebiotics, Medical Food & Other)
10.3 Market Segmentation By Disease (Obesity, Diabetes Type-II, Autoimmune Disorder, Cancer, Gastrointestinal Disorder & Others)
10.4 Market Segmentation By Application (Therapeutics & Diagnostics)

10.5 Europe Human Microbiome Market: Country Analysis
10.6 Market Opportunity Chart of Europe Human Microbiome Market - By Country, By Value (Year-2024)
10.7 Competitive Scenario of Europe Human Microbiome: By Country
10.8 United Kingdom Human Microbiome Market: Size and Forecast (2019-2024)
10.9 United Kingdom Human Microbiome Market Segmentation By Product, Disease, Application
10.10 Germany Human Microbiome Market: Size and Forecast (2019-2024)
10.11 Germany Human Microbiome Market Segmentation By Product, Disease, Application
10.12 France Human Microbiome Market: Size and Forecast (2019-2024)
10.13 France Human Microbiome Market Segmentation By Products, Disease, Application
10.14 Rest of the Europe Human Microbiome Market: Size and Forecast (2019-2024)
10.15 Rest of the Europe Human Microbiome Market Segmentation By Products, Disease, Application


11. Asia Pacific Human Microbiome Market: Segmentation By Products, Disease, Application (2019-2024)
11.1 Asia Pacific Human Microbiome Market: Size and Forecast (2019-2024)
11.2 Market Segmentation By Products (Probiotics, Prebiotics, Medical Food & Other)
11.3 Market Segmentation By Disease (Obesity, Diabetes Type-II, Autoimmune Disorder, Cancer, Gastrointestinal Disorder & Others)
11.4 Market Segmentation By Application (Therapeutics & Diagnostics)

11.5 Asia Pacific Human Microbiome Market: Country Analysis
11.6 Market Opportunity Chart of Asia Pacific Human Microbiome Market - By Country, By Value (Year-2024)
11.7 Competitive Scenario of Asia Pacific Human Microbiome: By Country
11.8 China Human Microbiome Market: Size and Forecast (2019-2024)
11.9 China Human Microbiome Market Segmentation By Product, Disease, Application
11.10 India Human Microbiome Market: Size and Forecast (2019-2024)
11.11 India Human Microbiome Market Segmentation By Product, Disease, Application
11.12 Japan Human Microbiome Market: Size and Forecast (2019-2024)
11.13 Japan Human Microbiome Market Segmentation By Products, Disease, Application
11.14 South Korea Human Microbiome Market: Size and Forecast (2019-2024)
11.15 South Korea Human Microbiome Market Segmentation By Products, Disease, Application
11.16 Rest of the Asia Pacific Human Microbiome Market: Size and Forecast (2019-2024)
11.17 Rest of the Asia Pacific Human Microbiome Market Segmentation By Products, Disease, Application


12. Rest of the World Human Microbiome Market: Segmentation By Products, Disease, Application (2019-2024)

12.1 Rest of the World Human Microbiome Market: Size and Forecast (2019-2024)
12.2 Market Segmentation By Products (Probiotics, Prebiotics, Medical Food & Other)
12.3 Market Segmentation By Disease (Obesity, Diabetes Type-II, Autoimmune Disorder, Cancer, Gastrointestinal Disorder & Others)
12.4 Market Segmentation By Application (Therapeutics & Diagnostics)


13. Global Human Microbiome Market Dynamics

13.1 Global Human Microbiome Market Drivers
13.2 Global Human Microbiome Market Restraints
13.3 Global Human Microbiome Market Trends


14. Market Attractiveness and Strategic Analysis

14.1 Market Attractiveness
14.1.1 Market Attractiveness Chart of Global Human Microbiome Market - By Products (Year 2024)
14.1.2 Market Attractiveness Chart of Global Human Microbiome Market - By Disease (Year 2024)
14.1.3 Market Attractiveness Chart of Global Human Microbiome Market - By Application (Year-2024)
14.1.4 Market Attractiveness Chart of Global Human Microbiome Market - By Region, By Value, (Year-2024)

14.2 Strategic Analysis
14.2.1 Key Developments in Human Microbiome Market
14.2.3 Human Microbiome Pipeline Projects

15. Competitive Landscape
15.1 Microbiome Licensing Deals Between Big Pharma and Biotech
15.2 Market Share Analysis
15.3 SWOT Analysis
15.4 Porter?s Five Force Analysis

16. Company Profiles (Business Description, Financial Analysis, Business Strategy)
16.1 OptiBiotix Health Plc
16.2 Metabiomics
16.3 OSEL Inc.
16.4 PureTech Health
16.5 4D Pharma
16.6 Synlogic Inc.
16.7 BaseClear BV
16.8 Rebiotix Inc
16.9 Ritter Pharmaceuticals
16.10 Assembly Bioscience Inc.